1. Anti-infection
  2. Bacterial
  3. NOSO-502

NOSO-502 是一种细菌翻译 (bacterial translation) 抑制剂。NOSO-502 对肠杆菌科显示出抑制活性。NOSO-502 具有良好的安全性和抗菌性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

NOSO-502 Chemical Structure

NOSO-502 Chemical Structure

CAS No. : 1894081-09-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

NOSO-502 is an inhibitor of bacterial translation. NOSO-502 exhibits inhibitory activity against Enterobacteriaceae. NOSO-502 has good safety and antibacterial properties[1].

体外研究
(In Vitro)

NOSO-502 (16 µg/mL 和 32 µg/mL;24 h) 使大肠杆菌 ATCC 25922 和肺炎克雷伯菌 ATCC 43816 菌株对 NOSO-502 产生抗性[1]
NOSO-502 (100 µM) 降低了 HRPTEpiC 细胞活性,但不显著增加热休克蛋白 27 (HSP27) 和肾损伤分子 1 (KIM-1) 的表达[1]
NOSO-502 的体外抗菌活性[1]

Citrobacter freundii DSM 30039 Citrobacter kozeri DSM 4595 Enterobacter aerogenes DSM 30053 Enterobacter cloacae DSM 14563 Escherichia coli ATCC 25922
MIC (µg/mL) 2 2 2 2 4
Klebsiella pneumoniae ATCC 43816 Serratia marcescens DSM 17174 Stenotrophomonas maltophilia ATCC 13637 Staphylococcus aureus ATCC 29213 Staphylococcus epidermidis ATCC 12228
MIC (µg/mL) 1 4 16 1 0.25

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

NOSO-502 (1.3-40 mg/kg;皮下注射;单剂量) 在感染大肠杆菌 EN122 的 NMRI 小鼠中显示出抗菌作用[1]
NOSO-502 (4-24 mg/kg;皮下注射;单剂量) 在感染大肠杆菌 UTI89 的 C3H/HeN 小鼠中显示出保护作用[1]
NOSO-502 (2-80 mg/kg;皮下注射;单剂量) 在感染肺炎克雷伯菌 NCTC 13442 的 CD-1/ICR 小鼠中显示出保护作用[1]
NOSO-502 的药代动力学 (PK) 参数[1]

Species Route Dose (mg/kg) Cmax (mg/L) AUC0-Tlast (mg/L•h) Vd (L/kg) T1/2 (min) Clearance (L/h/kg)
Mouse Intravenous injection 30 23.46 8.88 0.66 25 1.13
Rat Intravenous injection 15 40.70 7.99 0.94 90 1.92

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female NMRI mice infected E. coli EN122[1].
Dosage: 1.3, 2.5, 5, 10, 20, and 40 mg/kg.
Administration: Subcutaneous injection; single dose.
Result: Showed anti-infective effect.
Animal Model: Female C3H/HeN mice infected E. coli UTI89[1].
Dosage: 4, 12 and 24 mg/kg.
Administration: Subcutaneous injection; single dose.
Result: Significantly attenuated E. coli UTI89 damage to urine, bladder, kidneys, and improved survival rates.
Animal Model: Male CD-1/ICR mice infected K. pneumoniae NCTC 13442[1].
Dosage: 2, 6, 20 and 80 mg/kg.
Administration: Subcutaneous injection; single dose.
Result: Significantly improved lung tissue damage.
分子量

1078.24

Formula

C47H80FN17O11

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

NOSO-502 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
NOSO-502
目录号:
HY-123922
需求量: